SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending amid discussions around its growth potential, analyst ratings, and overall market sentiment. Community members are actively debating its valuation, with some citing strong revenue growth and potential benefits from future rate cuts, while others express concerns about dilution and overvaluation. The stock's movements are also being tied to broader market trends and upcoming economic data releases.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

$SNAP is trending as traders discuss potential catalysts including AI integration, a possible buyout, and speculation around increased interest from Reddit's WallStreetBets community. Community members are actively debating price targets, potential acquirers, and the impact of AI on the platform's future, while also noting the stock's high short interest and recent trading volume.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending as the FDA considers the ineffectiveness of phenylephrine, an ingredient in popular decongestants like Sudafed PE, potentially impacting sales. Despite this, some analysts remain bullish, citing attractive entry points and a recent addition to the S&P 500, with the community actively monitoring price movements for potential buying opportunities.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending amid discussions around its correlation to crypto markets and AI data center prospects, with some traders expressing frustration over its price action and potential manipulation. Community members are debating its valuation and future performance, particularly in relation to upcoming earnings and Helios updates. Bearish sentiment is emerging with some traders targeting lower price points.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending amid speculation about potential S&P 500 inclusion and excitement surrounding the launch of NFL and college football prediction markets on the platform. Community discussions revolve around whether the stock will be added to the S&P 500, with some anticipating a surge if it happens, while others focus on the potential revenue boost from the new sports betting feature. The stock's behavior relative to the broader market and key technical levels are also being closely monitored.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to positive sentiment around its role in AI and potential benefits from new export regulations impacting competitors. Community members are discussing Micron's commitment to AI education and the potential for increased demand for its HBM and DRAM products. Bullish sentiment is fueled by expectations of strong earnings and a possible breakout, with some anticipating significant gains in the coming months.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amid mixed sentiments following its reverse stock split, with community discussions focusing on whether the company can avoid further dilution. Some investors express optimism, citing potential for a short squeeze and the closing of the Uber investment, while others remain bearish due to the company's cash burn and lowered price targets. The stock's performance is also being viewed in the context of the broader EV sector and comparisons to other companies in the space.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond ($BBBY) is trending amid discussions about its new corporate name and ticker symbol after Overstock acquired the rights, sparking confusion among investors. The community is buzzing about the potential of Tzero, a blockchain platform associated with the company, and its possible impact on preventing naked shorting, drawing comparisons to the $GME saga. Some traders are expressing skepticism while others speculate on Ryan Cohen's next move and the potential for new stores.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is trending as investors discuss the potential impact of a recent FDA communication on their DMD drug, Deramiocel. Community members are analyzing the company's response and a potential new FDA approval pathway, while highlighting the drug's impact on patients. Some traders speculate on the likelihood of approval based on ongoing trials and are actively debating data endpoints.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI (SOUN) is trending as chatter increases around a potential short squeeze, driven by high short interest and bullish technical indicators. The community is also discussing recent partnerships in the healthcare sector and potential expansion into new verticals, with some speculating about a possible buyout. Bullish sentiment is building as traders focus on key price levels and the company's long-term potential in the AI voice space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Telsey Advisory Group maintained a ‘Less Risk’ rating on Caleres (CAL) after its quarterly results, stating that even as the broader footwear market remained challenged in the second quarter, the company was able to gain market share in several segments, like women's fashion and shoe chains.&nbsp;Dana Telsey of Telsey Advisory Group noted that tariffs weighed on the second quarter's margin and are expected to continue impacting the rest of the year. She added that sales declined due to continued pressure on value-priced brands and order cancellations linked to manufacturing in China.&nbsp;Retail sentiment on <a href="https://stocktwits.com/symbol/CAL">Caleres</a> remained unchanged in the ‘bullish’ territory, with message volumes at ‘high’ levels, according to data from Stocktwits. The retail user message count on the stock increased by 700% on Stocktwits over the last 24 hours, as of Friday morning.<figure class="image"><img style="aspect-ratio:816/105;" src="https://news.stocktwits-cdn.com/CAL_sentiment_png_117220490f.webp" alt="CAL sentiment.png" width="816" height="105"><figcaption>CAL sentiment and message volume September 5, 2025, as of 12:30 pm ET | Source: Stocktwits</figcaption></figure>Caleres reported second-quarter net sales of $658.5 million, compared with estimates of $656.5 million, according to data from Fiscal AI. Its adjusted earnings per share of $0.35 missed expectations of $0.56. Shares of the company were up 10% during midday trading on Friday.The brokerage noted that the continued suspension of annual guidance speaks to the challenging operating environment and makes visibility to the earnings potential in the shorter term more challenging.&nbsp;Caleres acquired Stuart Weitzman from Tapestry for $120.2 million, aiming to add a storied name in luxury footwear to its diverse brand portfolio.&nbsp;“The acquisition of Stuart Weitzman brings a quality brand name to the Brand Portfolio business that can add to the topline and future profitability potential, and we believe the brand can benefit from a true footwear pure-play owner,” Dana Telsey added.Caleres' shares have lost over 32% of their value this year and declined nearly 60% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/safe-and-green-s-olenox-hits-3-000-barrel-milestone-post-texas-acquisition-retail-chatter-surges-850/chwI0VNRdqO">Safe &amp; Green’s Olenox Hits 3,000-Barrel Milestone Post-Texas Acquisition, Retail Chatter Surges 850%</a>

 In this photo illustration, the Caleres Footwear company logo seen displayed on a smartphone.

Caleres Draws ‘Less Risk’ Rating From Telsey, Retail Chatter Surges 700%

Caleres reported second-quarter net sales of $658.5 million, compared with estimates of $656.5 million, according to data from Fiscal AI.

Equity

Cardinal Health (CAH) announced on Thursday the opening of a new distribution center in Fort Worth, Texas, and stated that it will also break ground on a new distribution center in Sacramento, California, this fiscal year.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CAH">CAH stock</a> stayed within ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.The new 340,000 square foot Texas facility marks the company’s third distribution center built from the ground up in just three years, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/cardinal-health-at-home-solutions-opens-texas-distribution-center-announces-plans-for-new-california-site-302545468.html">said</a>, while adding that it will ship approximately 10,000 packages containing critical medical supplies per day directly to people's homes across the country. &nbsp;The supplies will help manage conditions like diabetes, sleep apnea, and urological conditions, the firm added.The facility is dedicated to the company’s At-Home Solutions business, similar to its buildings in Ohio and South Carolina. The firm also stated that it will break ground on another new site fully dedicated to the at-Home Solutions business in Sacramento this fiscal year. The new Sacramento building is anticipated to be fully operational in summer 2027.Last month, Cardinal Health reported fourth-quarter revenue of $60.2 billion, up from $59.9 billion reported in the corresponding quarter of 2024 and adjusted earnings per share of $2.08, marking a growth of 13% year-on-year.The pharmaceutical and specialty solutions segment, as well as the global medical products and distribution segment, accounted for the majority of the company’s revenue during the period. CAH stock is up 26% this year and approximately 31% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/agios-pharma-stock-slumps-but-company-remains-top-pick-for-analyst/chwdJJlRdYs">Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Cardinal Health is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Cardinal Health Opens Distribution Center In Texas, Plans One In California 

The new Texas facility will ship approximately 10,000 packages containing critical medical supplies daily directly to people's homes nationwide.

Merck (MRK) announced on Tuesday that its investigational oral drug candidate, Enlicitide Decanoate, reduced low-density lipoprotein (LDL-C) cholesterol compared to a placebo in a late-stage trial evaluating the drug for the treatment of Hypercholesterolemia.Hypercholesterolemia is a disorder characterized by elevated LDL cholesterol levels in the blood. According to Merck, it affects about 86 million adults in the U.S. and increases the risk of cardiovascular diseases.The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.merck.com/news/mercks-investigational-oral-pcsk9-inhibitor-enlicitide-decanoate-met-all-primary-and-key-secondary-endpoints-in-adults-with-hypercholesterolemia-in-pivotal-coralreef-lipids-study/">stated</a> that treatment with Enlicitide resulted in a statistically significant and clinically meaningful reduction in low-density lipoprotein cholesterol compared to placebo at week 24. The investigational drug also reduced non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B (ApoB), and lipoprotein, the firm said.<a href="https://stocktwits.com/symbol/MRK">MRK shares</a> traded marginally higher in the pre-market session at the time of writing. On Stocktwits, retail sentiment around the stock fell from ‘neutral’ to ‘bearish’ over the past 24 hours, while message volume stayed at ‘low’ levels.According to Merck, discontinuations due to adverse events were low and comparable between treatment groups in the trial, which enrolled adults with hypercholesterolemia on a moderate or high intensity statin or with documented statin intolerance. Statins are medications that lower cholesterol by blocking an enzyme in the liver necessary for its production.Merck stated that it plans to share the study's results with regulatory authorities worldwide and present the data at a future scientific congress. Merck Research Laboratories President Deal Y. Li noted that this is the third late-stage trial to demonstrate clinically meaningful and statistically significant LDL-C lowering for Enlicitide.MRK stock is down by about 15% this year and by about 28% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/amazon-stock-slips-over-1-premarket-tech-giant-commits-4-4-b-to-new-zealand-investment/chv6VFeRdnk">Amazon Stock Slips Over 1% Premarket: Tech Giant Commits $4.4B To Expand Asia-Pacific Cloud Reach In New Zealand</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Merck’s Investigational Drug Shows Reduction In Cholesterol In Late-stage Trial

The company reported that treatment with Enlicitide led to a statistically significant and clinically meaningful reduction in low-density lipoprotein cholesterol compared to the placebo at week 24.

U.S. auto safety regulator stated on Tuesday that automaker General Motors (GM) is recalling 23,656 Chevrolet Corvette vehicles in the country over heightened risks of fire.The recall involves model year 2023-2026 Corvette vehicles equipped with a left-side radiator or fan combination, including some Corvette convertibles and coupes. Excess fuel may spill into the vehicle fuel-filler pocket during refueling and leak onto an ignition source such as a hot engine or exhaust components, increasing the risk of a fire, the National Highway Traffic Safety Administration (NHTSA) <a target="_blank" rel="noopener noreferrer nofollow" href="https://static.nhtsa.gov/odi/rcl/2025/RCLRPT-25V536-9882.pdf">said</a>.The regulator said that dealers will install a shield to divert spilled fuel, at no cost to the customer, to resolve the issue. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/GM">GM stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours, while message volume remained at ‘low’ levels.<figure class="image"><img style="aspect-ratio:576/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_9_04_07_AM_png_997caba829.webp" alt="GM's Sentiment Meter and Message Volume as of 9:04 a.m. ET on Aug. 26, 2025 | Source: Stocktwits" width="576" height="63"><figcaption>GM's Sentiment Meter and Message Volume as of 9:04 a.m. ET on Aug. 26, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user noted earlier that the stock will rally soon.<stembedurl>https://stocktwits.com/Derrick20042008/message/626503875</stembedurl>The recall follows an employee submitting a report to the company after reading a social media post alleging that three Corvette vehicles experienced a fire while fueling during a 30-day period. On June 12, a fourth incident occurred in a GM-owned development Corvette test vehicle. GM subsequently opened a product investigation on June 17.GM’s investigation identified four alleged fires that are potentially relevant to the condition. Customer reports, photographs, and video evidence indicated that malfunctioning filling station pumps were a contributing factor in at least two of the four field fires, GM said. It added that two of these incidents involved minor alleged injuries. The company then decided to conduct a safety recall.GM also said in the recall report that owners should always confirm that the fuel nozzle is completely inserted into the vehicle’s fuel pipe before fueling to reduce the risk of fire and turn off the vehicle’s engine during refuelling.GM stock is up by 13% this year and by about 19% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-incannex-healthcare-surging-today/chsHHZBRdjh">Why Is Incannex Healthcare Stock Surging Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A new 2025 Chevrolet Corvette on display at the Edmonton Motor Show on April 13, 2025, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

GM Recalls Nearly 24,000 Chevrolet Corvette Vehicles In The US: Find Out Why

The recall involves model year 2023-2026 Corvette vehicles equipped with a left-side radiator or fan combination, including some Corvette convertibles and coupes.

Four major truckmakers have sued California to block it from enforcing strict emissions standards, Reuters reported on Tuesday.Daimler, Volvo, Paccar (PCAR), and International Motors, formerly Navistar, filed a complaint in the federal court in Sacramento and named the California Air Resources Board (CARB) and Democratic Governor Gavin Newsom as defendants, the report <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/daimler-volvo-other-truckmakers-sue-california-block-emissions-rules-2025-08-12/">said</a>.<a href="https://stocktwits.com/symbol/PCAR">PCAR</a> stock traded 1% higher at the time of writing. Retail sentiment around the stock trended in the ‘bearish’ territory over the past 24 hours, coupled with ‘low’ message volume.Certain waivers enacted during the Biden administration allowed California to set its own emissions standards, including the end of the sale of gasoline-only vehicles in the state by 2035. &nbsp;President Donald Trump voided California’s emission standards in June. The state is now suing to undo Trump’s actions. &nbsp;The four truckmakers said they have been "caught in the crossfire" since. The truckmakers said that Trump rescinding U.S. Environmental Protection Agency approval of California's plan to boost zero-emission heavy-duty truck sales and reduce nitrogen oxide emissions preempted the state's enforcement. They said that this included enforcing a 2023 program called the Clean Truck Partnership, the report noted. &nbsp;The Clean Truck Partnership (CTP) is an agreement between CARB, the Truck and Engine Manufacturers Association (EMA), and other major truck manufacturers that represent over 90% of California’s truck market. The program gives the truckmaking industry flexibility to meet emissions requirements, provided they advance zero-emission technology, regardless of whether any other entity challenges California’s authority to set more stringent emissions standards.The complaint noted that the regulatory uncertainty has caused irreparable harm as the companies cannot plan production without knowing which vehicles they will have the permission to sell.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/pfizer-in-spotlight-as-fda-reportedly-mulls-withdrawing-authorization-for-covid-vaccine-for-kids-under-5/chrxIiKRdJL">Pfizer In Spotlight As FDA Reportedly Mulls Withdrawing Authorization For COVID-19 Vaccine For Kids Under 5: Retail Says Stock Is Undervalued</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Paccar logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

These Major Truckmakers Reportedly Sue California To Block Emissions Rules: Find Out More

According to a Reuters report, four truckmakers filed a complaint in the federal court in Sacramento and named the California Air Resources Board and Democratic Governor Gavin Newsom as defendants.

According to a Reuters report, Daimler, Volvo, Paccar (PCAR), and International Motors, formerly Navistar, filed a complaint in the federal court in Sacramento and named the California Air Resources Board and Democratic Governor Gavin Newsom as defendants.


Pharmaceutical distributor Cardinal Health (CAH) on Tuesday said its multi-specialty management services organization (MSO) platform is set to acquire healthcare platform Solaris Health.Cardinal Health will <a target="_blank" rel="noopener noreferrer nofollow" href="https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-announces-the-addition-of-Solaris-Health,-the-countrys-leading-urology-MSO,-to-The-Specialty-Alliance">provide</a> approximately $1.9 billion in cash to its MSO platform, called The Specialty Alliance, for the acquisition. Once the acquisition is completed, Cardinal will own about 75% of The Specialty Alliance.The company said that it intends to finance the acquisition with a combination of cash on hand and new debt financing.Shares of <a href="https://stocktwits.com/symbol/CAH">CAH</a> traded 6% lower in Tuesday’s pre-market session at the time of writing.The Specialty Alliance will buy Solaris Health from Lee Equity Partners and Solaris Health's physician owners. The deal will add over 750 providers across more than 250 practice locations in 14 states to its MSO platform, Cardinal said.Solaris CEO Gary Kirsh will retire from his role upon the closing of the transaction and serve as a Senior Advisor to Cardinal Health. The deal is expected to close by the end of the year, subject to conditions including the receipt of necessary approvals. Cardinal said that the deal is expected to be “slightly accretive” to its adjusted earnings per share in the first 12 months following close.On Stocktwits, retail sentiment around CAH jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.Separately, the company on Tuesday <a target="_blank" rel="noopener noreferrer nofollow" href="https://s201.q4cdn.com/566741227/files/doc_financials/2025/q4/Q4-FY25-Earnings-Press-Release.pdf">reported</a> its fourth-quarter results with revenue of $60.2 billion, falling short of a Wall Street estimate of $60.92 billion. Adjusted earnings per share, however, came in at $2.08, above an expected $2.03.For fiscal year 2026, the company now expects adjusted earnings per share of $9.30 to $9.50, up from its previous guidance of $9.10 to $9.30, and growth in revenue across its pharmaceutical, medical products, and other segments. CAH stock is up by 33% this year and by about 57% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/ethereum-leads-gains-after-record-1-b-etf-inflows-bitcoin-altcoins-slide/chrxTXuRd7u">Ethereum Leads Gains After Record $1B ETF Inflows – Bitcoin, Altcoins Slide Ahead Of Inflation Data</a>For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Cardinal Health To Provide $1.9B To Specialty Alliance Division To Enable Solaris Health Acquisition: More Details Inside

The deal will add over 750 providers across more than 250 practice locations in 14 states to its MSO platform, the company said. 

General Motors (GM) is seeking to bring back former Cruise employees in renewed efforts to develop a driverless car, Bloomberg <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-08-11/gm-plans-renewed-push-on-driverless-cars-after-cruise-debacle?srnd=homepage-americas">reported</a> on Monday, citing people familiar with the matter.The company would focus on developing autonomous cars for personal use this time, as compared to earlier, when it was looking to develop a robotaxi service, the report said. The plan was conveyed to employees in a meeting on August 6 by Sterling Anderson, the report said, citing sources. GM <a href="https://stocktwits.com/news-articles/markets/equity/gm-ropes-in-aurora-co-founder/chiNSWyRbmi">appointed</a> Anderson as executive vice president and chief product officer in May.Anderson said that the company is trying to bring back some Cruise workers and hire new staff for the automaker’s Mountain View, California, office, according to the report. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/GM">GM</a> trended in the ‘bearish’ territory over the past 24 hours, while message volume remained at ‘extremely low’ levels.In December, GM said it would no longer fund Cruise‘s robotaxi development but instead combine the majority-owned unit into its technical teams. The robotaxi development work needs considerable time and resources to scale, GM reasoned, while adding that the market is getting increasingly competitive.The company had said it would instead work on the progress of Super Cruise, its hands-off, eyes-on driving feature, deployed in passenger vehicles.&nbsp;Cruise was a major robotaxi player in Waymo's leagues until October 2023, when a Cruise robotaxi got involved in an accident in San Francisco, giving rise to heightened regulatory scrutiny, the exit of high-profile executives, including co-founder Kyle Vogt, and the suspension of robotaxi services.A few months later, GM said it was abandoning its plans to build the pedal-less Origin autonomous vehicle and said it would instead use its next-generation Chevrolet Bolt for autonomous driving purposes. Still, by December 2024, the company announced Cruise’s closure.GM stock is up by about 1% this year and by about 26% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/avantor-responds-to-activist-investor-engine-capital-letter/chru67IRde5">Avantor Responds To Activist Investor Engine Capital’s Letter: ‘Acting With Urgency To Strengthen Growth’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The hand of a statue appears in front of a view of office highrises of US car giant General Motors (GM) in Detroit, USA, 13 January 2013. Photo: Uli Deck | usage worldwide (Photo by Uli Deck/picture alliance via Getty Images)  

GM Renews Efforts To Develop Autonomous Cars After Cruise Shut Down: Report

According to a Bloomberg report, the company would focus on developing autonomous cars for personal use this time, as compared to earlier, when it was looking to develop a robotaxi service. 

ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani dismissed the impact of tariffs on the company, stating that over 90% of the total revenues come from finished goods manufactured in the U.S.“While we await the administration's pharmaceutical industry-specific framework, it is worth reiterating ANI's long-standing commitment to the U.S. Pharmaceutical industry and our positive and unique positioning relative to our peers,” the CEO said during the earnings call on Friday. “Products representing less than 5% of our total company revenues rely directly on imports from China. In addition, we have a strong balance sheet that enables us to carry healthy levels of finished goods and raw material inventories.”On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ANIP">ANIP</a> jumped from ‘bearish’ to ‘bullish’ over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:1334/128;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_08_at_12_37_09_PM_png_c2361a1206.webp" alt="ANIP's Sentiment Meter and Message Volume as of 12:35 p.m. ET on Aug. 8, 2025 | Source: Stocktwits" width="1334" height="128"><figcaption>ANIP's Sentiment Meter and Message Volume as of 12:35 p.m. ET on Aug. 8, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the company is “practically” 100% American-produced and based to help pacify any government demands.<stembedurl>https://stocktwits.com/Dy2ski/message/624331368</stembedurl>ANI Pharmaceuticals on Friday reported second-quarter net revenues of $211.4 million, representing year-over-year growth of 53.1%, and above an analyst estimate of $190.11 million, according to Fiscal AI data. The company attributed the increase in revenue to a doubling in net revenues from its rare diseases product segment to $104 million. Adjusted and diluted earnings per share came in at $1.80, above an expected $1.42. &nbsp;&nbsp;&nbsp;&nbsp;The company also raised its full-year guidance. ANI now expects full year net revenue of $818 million to $843 million and adjusted EPS of $6.98 to $7.35. The firm added that it expects its rare diseases portfolio to represent about 50% of its total net revenue in 2025.Piper Sandler analyst David Amsellem subsequently raised the firm's price target on ANI Pharmaceuticals to $94 from $80 while keeping an ‘Overweight’ rating on the shares.ANIP stock is up by 49% this year and by about 46% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-procures-rideshare-permit-in-texas/chrnKvjRd4I">Tesla Procures Rideshare Permit In Texas: Retail Expects Stock To Trade Over $330 Until Next Major Update</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

ANI Pharma Stock Shoots Through The Roof On Friday: CEO’s Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors

ANI said it expects full-year net revenue of $818 million to $843 million and adjusted EPS of $6.98 to $7.35.

Texas-based Noveon Magnetics said on Wednesday that it has entered into a multi-year supply agreement with automaker General Motors (GM) to deliver rare earth magnets.The company said that it began delivering magnets to support GM's full-size SUVs and trucks in July.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/GM">GM</a> trended in the ‘bearish’ territory over the past 24 hours while message volume remained at low levels.<figure class="image"><img style="aspect-ratio:625/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_06_at_9_59_35_AM_png_61d549fc38.webp" alt="GM's Sentiment Meter and Message Volume as of 9:59 a.m. ET on Aug. 6, 2025 | Source: Stocktwits" width="625" height="63"><figcaption>GM's Sentiment Meter and Message Volume as of 9:59 a.m. ET on Aug. 6, 2025 | Source: Stocktwits</figcaption></figure>"Working with domestic manufacturers like Noveon allows us to increase the resiliency of our supply chain while supporting American jobs and strengthening our industry and economic security," <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/driving-american-industry-general-motors--noveon-magnetics-sign-multi-year-agreement-to-deliver-american-made-rare-earth-magnets-302522804.html#:~:text=SAN%20MARCOS%2C%20Texas%2C%20Aug.,deliveries%20began%20in%20July%202025.">said</a> Jeff Morrison, General Motors' global chief procurement officer.The new agreement announcement comes on the heels of the company <a href="https://stocktwits.com/news-articles/markets/equity/gm-mary-barra-highlights-efforts-to-mitigate-tariff-impact-in-future-after-q2-earnings-take-hit/ch8M15MR5tG">committing</a> to grow its domestic supply chain during its second-quarter earnings call last month in an attempt to reduce the impact of tariffs imposed on imports.“For the full year, while there have been some puts and takes since we gave our initial guidance, our gross tariff impact remains unchanged at $4 billion to $5 billion this year as we continue to produce and import vehicles from Canada, Mexico and Korea to avoid interruptions for our customers and dealers,” company CFO Paul Jacobson said.However, the company is attempting to mitigate at least 30% of this $4 billion to $5 billion impact through manufacturing adjustments, targeted cost initiatives, and consistent pricing, it said.In Q2, GM incurred a $1.1 billion net impact from tariffs. The company also noted that it believes the third-quarter net impact will be higher than in Q2 due to the timing of indirect tariff costs.In June, GM announced a $4 billion investment into its U.S. assembly plants to add 300,000 units of capacity, and reduce tariff exposure on vehicle imports while continuing to satisfy customer demand.GM stock is down by 2% this year but up by about 28% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/mannkind-announces-500-million-financing-agreement-with-blackstone-after-q2-revenue-miss/chr1zwaRd5P">MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

GM Secures Rare Earth Magnet Supply From Texas Partner Amid Push to Mitigate Tariffs

Noveon Magnetics said that it began delivering magnets to support GM's full-size SUVs and trucks in July.

General Motors (GM) on Monday stated that its electric vehicle sales in the U.S. more than doubled year-over-year in July, thanks to the demand for its Chevrolet Equinox EV. &nbsp;GM <a target="_blank" rel="noopener noreferrer nofollow" href="https://news.gm.com/home.detail.html/Pages/topic/us/en/2025/aug/0804-ev.html">said </a>that it sold more than 19,000 electric vehicles in the month, marking a growth of 115% year-on-year. The company sold more than 8,500 units of the Equinox EV alone in the month, implying the model accounted for about 45% of the company’s overall EV sales. &nbsp;“That’s not just the best U.S. sales month ever for Equinox EV–it is the best ever for a non-Tesla EV in the U.S.,” GM said in a statement.The company noted that demand for EVs is surging as the federal tax credit on the purchase of EVs nears expiration. As per GM, EV sales are expected to increase to about 8.5% of industry sales in July.&nbsp;On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/GM">GM</a> trended in the ‘bearish’ territory, while message volume remained at ‘low’ levels.<figure class="image"><img style="aspect-ratio:1338/132;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_04_at_2_27_43_PM_png_1139635fbc.webp" alt="GM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Aug. 4, 2025 | Source: Stocktwits" width="1338" height="132"><figcaption>GM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Aug. 4, 2025 | Source: Stocktwits</figcaption></figure>President Donald Trump signed the Republican tax bill into law on the Fourth of July. Under the new law, tax credits for the purchase of electric vehicles will expire on September 30. This includes the $7,500 federal tax credit on the purchase of new EVs and the $4,000 credit on buying used ones.The expiry of federal tax credits will weigh on multiple automakers selling EVs, including GM’s competitors, Ford (F) and Tesla (TSLA), whose certain vehicles also currently qualify for the tax credit. The Equinox EV is presently eligible for a federal tax credit of $7,500, as are the Chevrolet Blazer EV and the Silverado EV.Certain other models from GM, belonging to different brands such as Cadillac and GMC, are also eligible for the tax credit, including the Cadillac Lyriq and the GMC Sierra EV.The Equinox EV went on sale in May 2024. The base and cheapest variant of the SUV starts at around $35,000, placing it among more affordable EVs from U.S. automakers such as the Tesla Model 3.Last month, GM CEO Mary Barra noted that there was demand for EVs before the federal tax credit, and that real EV demand would be apparent in 2026 once the federal tax credit on the purchase of new EVs ends in September. “We think there is going to be an EV market that will grow over time, albeit it'll start lower and potentially grow more slowly,” Barra then said while reiterating the company’s commitment to making EVs to meet consumer demand.GM stock is down by 1% this year but up by nearly 33% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/joby-aviation-announces-purchase-of-blade-urban-air-mobility-business/chrXN6wRdTY">Joby Aviation Stock Flies 15% After Company Announces Purchase Of Blade’s Urban Air Mobility Business: Retail’s Not Entirely Convinced</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the logo of General Motors is seen on a smartphone screen with a steering wheel in the background. (Photo Illustration by Serene Lee/SOPA Images/LightRocket via Getty Images)

GM More Than Doubles EV Sales In July Ahead Of Federal Tax Credit Expiry: Chevrolet Equinox EV Leads Pack

GM said that it sold more than 19,000 electric vehicles in the month, marking a growth of 115% year-on-year.

VFMF
Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VFMF News

VFMF Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF